Akhil Anand

ORCID: 0000-0003-4132-2690
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Psychedelics and Drug Studies
  • Alcoholism and Thiamine Deficiency
  • Emergency and Acute Care Studies
  • Chemical synthesis and alkaloids
  • Neurological and metabolic disorders
  • Sleep and related disorders
  • Neurotransmitter Receptor Influence on Behavior
  • Cannabis and Cannabinoid Research
  • Mental Health Treatment and Access
  • Alcohol Consumption and Health Effects
  • Infectious Encephalopathies and Encephalitis
  • COVID-19 and Mental Health
  • Liver Disease Diagnosis and Treatment
  • Pharmaceutical Practices and Patient Outcomes
  • Homelessness and Social Issues
  • Opioid Use Disorder Treatment
  • Substance Abuse Treatment and Outcomes
  • Liver Disease and Transplantation
  • Geriatric Care and Nursing Homes
  • Health, Environment, Cognitive Aging
  • Biochemical Analysis and Sensing Techniques
  • Pain Management and Opioid Use
  • COVID-19 and healthcare impacts
  • Piperaceae Chemical and Biological Studies
  • Mental Health Research Topics

Cleveland Clinic
2021-2025

Cleveland Clinic Lerner College of Medicine
2022-2024

Case Western Reserve University
2022-2024

University Hospitals of Cleveland
2024

MetroHealth
2024

Wright State University
2024

University School
2024

MetroHealth Medical Center
2024

Yale University
2024

Mayo Clinic
2023

Though lysergic acid diethylamide (LSD) use is rising in the United States amid expanding research into therapeutic potential of psychedelics, little scholarly work exists on whether perceived risk trying LSD (prLSD) changing or factors influencing prLSD among general public. Therefore, we sought to investigate changes from 2015 2019 and identify characteristics associated with respondents National Survey Drug Use Health (NSDUH). Using NDSUH data 2019, investigated correlates temporal trends...

10.1089/psymed.2023.0027 article EN Psychedelic Medicine 2024-01-09

Background: We analyzed early outcomes regarding the impact of our integrated alcohol-associated liver disease (ALD) clinic on patients with ALD and alcohol use. Methods: conducted a retrospective study who were evaluated in from May 1, 2022, to December 31, 2023. Primary included differences baseline clinical/demographic data between accepted versus declined an appointment changes severity ALD, consumption, functional status, hospital utilization, remission use disorder for patients....

10.1097/hc9.0000000000000603 article EN cc-by-nc-nd Hepatology Communications 2025-02-01

Abstract Background Hospitalization and mortality in patients with alcohol‐associated hepatitis (AH), a severe form of liver disease, continue to increase over time. Given the severity illness, most hospitalized AH are admitted from emergency department (ED). However, there no data on ED utilization by AH. Thus, Nationwide Emergency Department Sample (NEDS) dataset was analyzed determine for Methods Temporal trends (2016–2019) outcomes visits were determined. Primary or secondary diagnoses...

10.1111/acer.15223 article EN Alcohol Clinical and Experimental Research 2024-01-01

Abstract Background Lysergic acid diethylamide (LSD) use has risen in the United States recent years amid increased interest therapeutic applications of psychedelics. Despite this, contemporary epidemiological investigations LSD users are few. To expand literature on this topic, we sought to characterize past-year and investigate demographic evolution within population. Methods Using National Survey Drug Use Health (NSDUH) data from 2015–2019, investigated correlates associated changes over...

10.1556/2054.2024.00309 article EN cc-by-nc Journal of Psychedelic Studies 2024-02-01

10.1016/j.jagp.2022.09.008 article EN American Journal of Geriatric Psychiatry 2022-09-24

Abstract Purpose To compare emergency department (ED) utilization and admission rates for patients with a history of mental health (MH), substance use disorder (SUD) social determinants (SDOH) before after implementing COVID-19’s shelter-in-place (SIP) orders. Methods This was retrospective, multicenter study leveraging electronic medical record data from 20 EDs across large Midwest integrated healthcare system 5/2/2019 to 12/31/2019 (pre-SIP) 5/2/2020 12/31/2020 (post-SIP). Diagnoses were...

10.1101/2023.10.25.23297561 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2023-10-26

We report the case of a 32-year-old male with autism spectrum disorder (ASD) suffering from severe misophonia. After titrating risperidone to 2 mg twice day, patient reported significant reduction in his symptoms and Amsterdam misophonia scale-revised (AMISOS-R) score dropped by 31 5. Upon discharge, was noted have decreased irritability overall improved behavior effect. This symptomatic improvement likely not explained inpatient admission alone or other simultaneous pharmacologic...

10.1155/2022/3169834 article EN cc-by Case Reports in Psychiatry 2022-09-30

Objectives: This study aims to compare emergency department (ED) utilization and admission rates for patients with a history of mental health (MH) disorders, substance use disorders (SUDs), social determinants (SDOH) before after implementing COVID-19 shelter-in-place (SIP) orders. Methods: was retrospective, multicenter leveraging electronic medical record (EMR) data from 20 EDs across large Midwest integrated healthcare system 5/2/2019 12/31/2019 (pre-SIP) 5/2/2020 12/31/2020 (post-SIP)....

10.7759/cureus.60556 article EN Cureus 2024-05-18

Wernicke's encephalopathy (WE) is a dangerous and potentially fatal neurological condition associated with thiamin deficiency. The standard treatment for WE intravenous (IV) thiamin, but limited research describes optimal dosing. We present case of 40-year-old male severe alcohol use disorder (AUD) chronic malnourishment who developed WE. Upon administration 100 mg IV symptoms persisted, when the dose was increased to 500 mg, altered mental status ophthalmoplegia resolved rapidly. reliable...

10.1080/10550887.2024.2365002 article EN Journal of Addictive Diseases 2024-07-01

The COVID-19 pandemic has resulted in a greater incidence of alcohol-associated liver disease (ALD) and simultaneously magnified health-related inequalities. We evaluated the impact race ethnicity on ALD-related hospitalizations Brazil.

10.1016/j.aohep.2024.101742 article EN cc-by-nc-nd Annals of Hepatology 2024-12-01
Coming Soon ...